Coherent Market Insights released on September 20, 2021
Global PTA Balloon Catheter Market
PTA stands for "Percutaneous Transluminal Angioplasty". The tip of the PTA balloon catheter has an inflatable "balloon", which is usually used for minimally invasive catheterization procedures. This procedure is used to enlarge narrowed blood vessel openings. The deflated balloon is placed in a narrow space, inflated for a short time, and then deflated again to take it out. PTA balloons come in various sizes, lengths, and shapes, depending on the anatomy they are treating. The PTA balloon catheter can be used to treat peripheral vascular disease in two ways. One method is to enlarge the lumen of the blocked blood vessel. This method is called "Plain Balloon Angioplasty" (POBA). The second use is to expand the stent to treat blood vessel obstruction.
In 2017, the global PTA balloon catheter market was estimated to be USD 1,127.7 million, and it is expected that the compound annual growth rate during the forecast period (2018-2026) will reach an astonishing 6.8%.
Obtain a sample copy of the 2021 PTA Balloon Catheter Market Report
The increasing prevalence of urinary system and cardiovascular diseases has promoted the expansion of the global PTA balloon catheter market
The increasing prevalence of urinary system and cardiovascular diseases is expected to increase the demand for PTA balloon catheters, which in turn is expected to drive the growth of the PTA balloon catheter market during the forecast period. Urinary system diseases include urinary tract infections, kidney stones and prostate problems. According to the American Cancer Society, there were approximately 174,650 new cases and approximately 31,620 deaths from prostate cancer in the United States in 2019. The National Institute of Diabetes, Digestive and Kidney Diseases reported in 2017 that approximately 11% of men and 6% of women suffer from kidney stones in the United States.
As reported by the World Health Organization (WHO), cardiovascular diseases account for the majority of non-communicable disease deaths recorded globally. In 2016, an estimated 17.9 million people died of cardiovascular disease, accounting for 31% of global deaths. Of these deaths, 85% were due to heart attacks and strokes. Therefore, the increasing prevalence of non-communicable diseases is expected to increase the demand for catheters, which in turn is expected to drive the growth of the PTA balloon catheter market during the forecast period.
See the press release for more information
Launching new products to boost the growth of the North American market
Major PTA balloon catheter manufacturers are focusing on launching new products in North America to increase their global market share. For example, in February 2016, Nipro North America, a division of Nipro Medical Corporation, announced the launch of the Cronus HP high-pressure, 0.035-inch online (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter. Cronus HP is suitable for percutaneous transluminal angioplasty of femoral artery, popliteal artery, iliac artery and renal artery, as well as treatment of obstructive diseases of natural or synthetic arteriovenous dialysis fistula.
In February 2017, QT Vascular Ltd. signed an exclusive global distribution agreement with Medtronic to distribute Chocolate PTA balloon catheters. It is currently available in the United States and Europe. In addition, in May 2015, Direct Access Medical announced that its full range of FirstChoice ultra-high pressure (UHP) percutaneous transluminal angioplasty (PTA) 0.035 inch steel wire balloon has been approved by the U.S. Food and Drug Administration for 510(k) catheters .
Buy this advanced report now to grow your business: https://www.coherentmarketinsights.com/insight/buy-now/2815
Well-known companies operating in the global PTA balloon catheter market include Medtronic, Terumo, Cardinal Health, Boston Scientific, AndraTec, Cook Medical, Biotronik, Abbott, Creagh Medical, TriReme Medical and Natec Medical.
Coherent Market Insights is a global market intelligence and consulting organization dedicated to helping many of our clients achieve transformational growth by helping them make key business decisions. We are headquartered in India, with offices in Global Financial Capital in the United States, and sales consultants in the United Kingdom and Japan. Our customer base includes participants from various business verticals in more than 150 countries/regions around the world. We are proud to cater to customers in all fields, from Fortune 500 companies to non-profit organizations, and startups that want to gain a foothold in the market. We are good at providing unparalleled actionable market intelligence in various vertical industries, including chemicals and materials, healthcare, food and beverages, consumer products, packaging, semiconductors, software and services, telecommunications, and automobiles. We provide joint market intelligence reports, customized research solutions and consulting services.
Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, US Email: sales@coherentmarketinsights.com United States: +1-206-701-6702 United Kingdom: +44-020-8133-4027 Japan: +050 -5539- 1737 India: +91-848-285-0837
Register and submit press release
Medical technology changes the world! Join us to see progress in real time. At Medgadget, we report on the latest technology news, interviews with leaders in the field, and document delivery of medical events around the world since 2004.